TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·July 29, 2026

Humana Inc. (HUM) drops 6.7% despite earnings beats

Humana Inc. (HUM) drops 6.7% even after reporting earnings beats, as investors react to outlook concerns and broader pressure on managed care shares.

Earnings FlashHUMHealthcareMedical - Healthcare Plans
By TickerSpark·July 29, 2026·2 min read
Humana Inc. (HUM) drops 6.7% despite earnings beats
▌Key Takeaway
Humana Inc. (HUM) reported a solid earnings beat, posting $7.61 in EPS versus $7.26 expected and $40.87 billion in revenue versus $40.57 billion expected. Despite the fifth straight EPS beat, the stock fell 6.7% to $362.66, signaling investors were not satisfied with the quarter’s broader outlook or guidance.

Humana Inc. (HUM) Drops Despite Earnings Beat

Humana Inc. (HUM) beat estimates with $7.61 EPS and $40.87B in revenue, yet the stock dropped 6.70% to $362.66 in regular-session trading.

Key Numbers

  • EPS: $7.61 actual vs. $7.26 estimated, a beat.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Revenue: $40.87B actual vs. $40.57B estimated, a beat.
  • Stock reaction: HUM closed at $362.66, down 6.70% from $388.71.
  • Regular-session range: $356.50 to $395.30.
  • Earnings trend: HUM has beaten EPS estimates in each of its last five reported quarters.

    • A Solid Beat Meets a Skeptical Market

    The quarter delivered a clear headline beat. EPS topped estimates, and revenue also cleared forecasts. The result extends HUM's five-quarter EPS beat streak, including $10.31 versus $10.24 in April and $3.24 versus $2.93 in November.

    The market response was sharply negative. HUM traded across a wide $38.80 range before closing lower. Volume reached 1,246,474 shares, below the 1,512,632 average. The price action shows that headline earnings strength did not translate into buying pressure.

    On the earnings call, investors should focus on any explanation for the gap between the $7.61 EPS and $40.87B revenue beats and the selloff. The five-quarter streak supports near-term earnings execution, but the 6.70% decline shows the market did not reward that execution in this session.

    Get AI research on any stock

    Instant reports, daily intelligence, and an AI analyst in your pocket.

    Get Started →

    Bottom Line

    HUM delivered a fifth straight EPS beat, but the 6.70% drop shows investors treated the quarter as insufficient.

    Read the full HUM research report
    ▌Common Questions

    Frequently asked questions

    +Why did Humana stock fall after beating earnings?
    Humana Inc. (HUM) beat estimates with $7.61 EPS and $40.87 billion in revenue, but the stock still dropped 6.70% to $362.66. The market’s reaction suggests investors focused on factors beyond the headline beat, such as guidance, margins, or the broader outlook.
    +Did Humana beat EPS and revenue this quarter?
    Yes. Humana reported $7.61 in EPS versus $7.26 expected and revenue of $40.87 billion versus $40.57 billion expected. This extended its streak to five straight quarters of beating EPS estimates.
    +How much did HUM stock move after earnings?
    Humana shares closed at $362.66, down 6.70% from $388.71 in regular-session trading. The stock traded in a wide range between $356.50 and $395.30 during the session.
    +What does Humana's earnings beat mean for investors?
    The beat shows Humana is still executing well on earnings, with five consecutive quarters of EPS outperformance. However, the sharp selloff indicates investors may want more than a modest beat before rewarding the stock.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on HUM?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the HUM report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full HUM research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the HUM report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on HUM

    More to read

    All articles
    Humana Inc. (HUM) jumps 16% on Medicare Advantage boost
    HUM

    Humana Inc. (HUM) jumps 16% on Medicare Advantage boost

    Humana Inc. (HUM) jumps after CMS 2027 Medicare Advantage Star Ratings showed 95% of members in plans rated 4 stars or above. The company’s flagship H5216 contract also returned to 4 stars, restoring bonus-payment eligibility and improving the outlook for revenue and margins.

    Oct 9·5 min
    Humana (HUM): Medicare Advantage Recovery in Progress
    HUM

    Humana (HUM): Medicare Advantage Recovery in Progress

    Humana’s Buy case hinges on a rebound in Medicare Advantage economics, improving operating efficiency, and CenterWell growth. The stock still faces meaningful reimbursement, Star Ratings, and medical cost risk.

    Oct 9·22 min
    Humana Inc. (HUM) climbs 13% on 2027 Star Ratings
    HUM

    Humana Inc. (HUM) climbs 13% on 2027 Star Ratings

    Humana Inc. (HUM) climbs after CMS released 2027 Medicare Advantage Star Ratings, lifting its largest contract back to 4 stars from 3.5. The upgrade improves the outlook for bonus payments, rebates, and enrollment competitiveness, while recent earnings strength adds support to the move.

    Oct 8·5 min